Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)

NCT04372589 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Pneumonia

Interventions

DRUG: Heparin

Sponsor

University of Manitoba

Collaborators

[object Object]